Press releases | WebDisclosure

Basculer en Français

9587	Companies
190041	Keywords
121569	Articles
101303	Press releases

Home
Press releases

PRESS RELEASE

published on 04/23/2025 at 20:47, 8 months 9 days ago

H2APEX receives shareholder loan and plans capital increase for further expansion of its hydrogen production capacities
H2APEX secures EUR 35M for hydrogen production expansion; plans EUR 30M capital increase, signs loan agreement and comfort letter, targets industrial-scale growth in Germany

Capital Increase H2APEX Hydrogen Production Shareholder Loan Industrial-scale Growth
PRESS RELEASE

published on 04/23/2025 at 20:42, 8 months 9 days ago

EQS-Adhoc: H2APEX Group SCA: Issuance of a Convertible Loan and a Comfort Letter; Planning of a Capital Increase
H2APEX Group SCA plans EUR 30 million capital increase through convertible loan issuance and comfort letter, aiming for business model development

Capital Increase H2APEX Group SCA Business Model Convertible Loan Comfort Letter
PRESS RELEASE

published on 04/23/2025 at 20:30, 8 months 9 days ago

Inside Information / Other news releases
GenSight Biologics to hold Annual General Meeting on May 13, 2025 at 2:00 pm CEST in Paris, France. Procedures for obtaining preparatory documents outlined

Annual General Meeting Preparatory Documents GenSight Biologics Gene Therapies Retinal Diseases
PRESS RELEASE

published on 04/23/2025 at 20:30, 8 months 9 days ago

Informations privilégiées / Autres communiqués
GenSight Biologics annonce son Assemblée Générale Mixte le 13 mai 2025 à Paris. Documents préparatoires disponibles en ligne

Documents Préparatoires Assemblée Générale Mixte GenSight Biologics Thérapies Géniques Neurodégénératives
PRESS RELEASE

published on 04/23/2025 at 20:03, 8 months 9 days ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Funding Circle Holdings plc repurchases 46,436 ordinary shares on the London Stock Exchange for cancellation at prices between 104.40p and 108.20p

London Stock Exchange Share Repurchase Cancellation Funding Circle Holdings PLC Investec
PRESS RELEASE

published on 04/23/2025 at 19:35, 8 months 9 days ago

Cibox : Résultats Annuels 2024 et Chiffre d'affaires T1 2025
CIBOX publie ses résultats annuels 2024 avec un doublement du chiffre d'affaires, une dynamique positive et une bonne performance commerciale. Prévision de croissance pour 2025

Chiffre D'affaires Croissance Résultats Annuels CIBOX Micro-mobilité
PRESS RELEASE

published on 04/23/2025 at 19:00, 8 months 9 days ago

DÉCALAGE DE LA PUBLICATION DES COMPTES SEMESTRIELS 2024-2025 AU 29 AVRIL 2025
HRS, leader européen des stations de ravitaillement en hydrogène, reporte la publication de ses comptes semestriels 2024-2025 du 24 au 29 avril 2025 après bourse pour finaliser les travaux en normes IFRS

IFRS Hydrogène HRS Stations De Ravitaillement Comptes Semestriels
PRESS RELEASE

published on 04/23/2025 at 19:00, 8 months 9 days ago

POSTPONEMENT OF THE PUBLICATION OF THE 2024-2025 HALF-YEAR FINANCIAL STATEMENTS TO APRIL 29, 2025
HRS, French hydrogen refueling solutions leader, delays the financial statement publication to ensure accuracy. Offers modular stations & comprehensive services

Innovation Financial Statements HRS Hydrogen Refueling Modular Stations
PRESS RELEASE

published on 04/23/2025 at 18:59, 8 months 9 days ago

AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
AB Science's AB8939 granted orphan drug designation by EMA in EU for treating acute myeloid leukemia, showing significant benefit over current therapies. Preclinical data reveals efficacy and safety

Orphan Drug Designation AB Science EMA AB8939 Acute Myeloid Leukemia
PRESS RELEASE

published on 04/23/2025 at 18:59, 8 months 9 days ago

La molécule AB8939 obtient la désignation de médicament orphelin auprès de l'EMA dans le traitement de la leucémie myéloïde aigue
La molécule AB8939 obtient la désignation de médicament orphelin dans l'Union Européenne pour le traitement de la leucémie myéloïde aigüe. AB Science fait un pas important dans le domaine de la recherche médicale

Traitement AB Science Médicament Orphelin AB8939 Leucémie Myéloïde Aiguë

Accesswire

Published on 01/03/2026 at 02:00, 4 hours 10 minutes ago

Battery X Metals Advances Development of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Machine with Compatibility Targeting the #1 Selling Electric Vehicle Brand in the United States
Published on 01/02/2026 at 23:00, 7 hours 10 minutes ago

Pinetree Capital Announces Chief Investment Officer's Return from Leave of Absence
Published on 01/02/2026 at 22:45, 7 hours 25 minutes ago

ATHA Energy Announces Grant of Compensation Securities
Published on 01/02/2026 at 19:50, 10 hours 20 minutes ago

Datavault AI and The Dream Bowl to Set New Benchmark in Sports Innovation with World’s First Tokenized Autograph Session, Featuring Current and Future NFL Stars - Live on ESPN+
Published on 01/02/2026 at 15:00, 15 hours 10 minutes ago

Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

View all ACCESSWIRE

EQS Group

Published on 01/03/2026 at 04:25, 1 hour 45 minutes ago

CGTN: Extraordinary Navigation: How China strides forward with confidence
Published on 01/02/2026 at 21:29, 8 hours 40 minutes ago

Crédit Mutuel Alliance Fédérale completes the acquisition of OLB and scales up in Germany
Published on 01/02/2026 at 18:55, 11 hours 15 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 01/02/2026 at 18:43, 11 hours 27 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/02/2026 at 18:25, 11 hours 45 minutes ago

Bitmine Publishes New Chairman's Message Explaining Why Shareholders Should Vote YES to Approve the Amendment to Increase Authorized Shares

Les Echos

Published on 01/02/2026 at 17:45, 12 hours 25 minutes ago

Mise en ligne du document « Pre-FY 2025 Results Communication »
Published on 01/02/2026 at 17:45, 12 hours 25 minutes ago

Availability of the Pre-FY 2025 Results Communication
Published on 12/29/2025 at 19:14, 4 days 10 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 22 au 26 décembre 2025 dans le cadre du programme de rachat d’actions.
Published on 12/29/2025 at 18:05, 4 days 12 hours ago

Covivio - Déclaration des transactions sur actions propres réalisées du 22 décembre au 24 décembre 2025
Published on 12/29/2025 at 18:05, 4 days 12 hours ago

Covivio - Treasury shares transactions between December 22nd , 2025 and December 24th, 2025

View all LES ECHOS COMFI WIRE